A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

NCT00411398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

General Anxiety Disorder, Social Anxiety Disorder

Interventions

DRUG: Namenda/Memantine

Sponsor

State University of New York - Upstate Medical University